GSK Investigational Site

Basingstoke RG24 9NA

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Cholestasis

Studies at this site

• Linerixibat Long-term Safety, and Tolerability Study — Running, not enrolling
• Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis — Completed
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) — Completed